Psoriasis

  • Clobex 2015 report

    Clobex 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 18 Pages The 5 Key Questions Addressed by this...

  • Cosentyx 2015 report

    Cosentyx 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 18 Pages The 5 Key Questions Addressed by this...

  • Enbrel 2015 report

    Enbrel 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 23 Pages The 5 Key Questions Addressed by this...

  • Humira 2015 report

    Humira 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 28 Pages The 5 Key Questions Addressed by this...

  • Otezla 2015 report

    Otezla 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Otrexup 2015 report

    Otrexup 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this...

  • Rasuvo 2015 report

    Rasuvo 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Remicade 2015 report

    Remicade 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 30 Pages The 5 Key Questions Addressed by this...

  • Stelara 2015 report

    Stelara 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Clobex 2014 report

    Clobex 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this...

  • Enbrel 2014 report

    Enbrel 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 23 Pages The 5 Key Questions Addressed by this...

  • Humira 2014 report

    Humira 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 28 Pages The 5 Key Questions Addressed by this...